Skip to content

CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.: 10-Q filed 2024-10-21

What CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. reported in its quarterly report filed 2024-10-21 (fiscal Q1 2025): 31 published measures, 66 facts as tagged in accession 0001683168-24-007261.

This filing

Form
10-Q (quarterly report)
Filed
2024-10-21
Fiscal period
fiscal Q1 2025
Accession
0001683168-24-007261 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-08-3146,280USD
At 2024-05-3157,162USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-08-311,101,597USD
At 2024-05-311,136,175USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2024-08-31-1,055,317USD
At 2024-05-31-1,079,013USD
At 2023-08-31-717,454USD
At 2023-05-31-591,665USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-06-01 to 2024-08-31-76,305USD92
2023-06-01 to 2023-08-31-181,789USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-06-01 to 2024-08-31-30,413USD92
2023-06-01 to 2023-08-31-74,620USD92

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2024-06-01 to 2024-08-31178,887USD92
2023-06-01 to 2023-08-3172,821USD92

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-06-01 to 2024-08-3130,627USD92
2023-06-01 to 2023-08-3170,453USD92

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-08-31-5,410,385USD
At 2024-05-31-5,334,081USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-06-01 to 2024-08-3110,458,923,260shares92
2023-06-01 to 2023-08-3110,331,749,347shares92

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-06-01 to 2024-08-3110,458,923,260shares92
2023-06-01 to 2023-08-3110,331,749,347shares92

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-06-01 to 2024-08-31-0.000007USD/shares92
2023-06-01 to 2023-08-31-0.00002USD/shares92

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-06-01 to 2024-08-31-0.000007USD/shares92
2023-06-01 to 2023-08-31-0.00002USD/shares92

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-06-01 to 2024-08-31-97,604USD92
2023-06-01 to 2023-08-31-176,784USD92

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-08-3118,743USD
At 2024-05-3121,492USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-08-31852,097USD
At 2024-05-31881,908USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2024-08-3117,176USD
At 2024-05-3120,139USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-06-01 to 2024-08-31268,129USD92
2023-06-01 to 2023-08-31240,785USD92

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2024-06-01 to 2024-08-31170,525USD92
2023-06-01 to 2023-08-3164,001USD92

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2024-06-01 to 2024-08-318,362USD92
2023-06-01 to 2023-08-318,820USD92

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-08-3110,556,749,347shares
At 2024-05-3110,431,749,347shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2024-08-31969USD
At 2024-05-31755USD
At 2023-08-314,746USD
At 2023-05-318,913USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2024-08-314,355,068USD
At 2024-05-314,255,068USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2024-08-3127,537USD
At 2024-05-3135,670USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2024-08-3122,225USD
At 2024-05-3126,873USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2024-08-31256,554USD
At 2024-05-31256,415USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2024-06-01 to 2024-08-3161,296USD92
2023-06-01 to 2023-08-3148,083USD92

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2024-06-01 to 2024-08-312,339USD92
2023-06-01 to 2023-08-315,005USD92

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2024-06-01 to 2024-08-3121,299USD92
2023-06-01 to 2023-08-31-5,005USD92

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2024-06-01 to 2024-08-312,339USD92
2023-06-01 to 2023-08-315,005USD92

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2024-06-01 to 2024-08-310USD92
2023-06-01 to 2023-08-310USD92

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2024-06-01 to 2024-08-31-2,963USD92
2023-06-01 to 2023-08-3117,444USD92

Inspect the source

Entity
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. / CIK 0001411057
Captured
2026-09-20T08:01:51.094Z
SEC response SHA-256
65039acad959501dea2ae2bfec13b3503da3ac05045712ff74cd71cfd51e2523

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001411057.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))